TY - JOUR
T1 - Evaluation of Patients with Suspected Gastroparesis
AU - Szarka, Lawrence A.
AU - Camilleri, Michael
N1 - Funding Information:
Disclosure Statement: Dr M. Camilleri has research funding from Takeda for a study of TAK954 for gastroparesis. He has acted as a consultant to Ironwood, Takeda and Allergan regarding gastroparesis (with consulting fee going to his employer, Mayo Clinic). Dr L.A. Szarka has no conflicts of interest to disclose.
Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2019/1
Y1 - 2019/1
N2 - There is substantial overlap between the symptoms of gastroparesis and a variety of alternative disorders. These conditions include rumination syndrome, drug-induced gastric emptying delay, cannabinoid hyperemesis syndrome, and eating disorders, which can be identified based on the history alone. The remaining patients require a diagnostic approach of physical examination, laboratory tests, evaluation with esophagogastroduodenoscopy or contrast radiography, and a test to measure gastric emptying. Symptomatic patients who have normal nutritional status and gastric emptying that is either normal or mildly delayed should be diagnosed with functional dyspepsia, whereas patients with moderate or severe gastric emptying delay are diagnosed with gastroparesis.
AB - There is substantial overlap between the symptoms of gastroparesis and a variety of alternative disorders. These conditions include rumination syndrome, drug-induced gastric emptying delay, cannabinoid hyperemesis syndrome, and eating disorders, which can be identified based on the history alone. The remaining patients require a diagnostic approach of physical examination, laboratory tests, evaluation with esophagogastroduodenoscopy or contrast radiography, and a test to measure gastric emptying. Symptomatic patients who have normal nutritional status and gastric emptying that is either normal or mildly delayed should be diagnosed with functional dyspepsia, whereas patients with moderate or severe gastric emptying delay are diagnosed with gastroparesis.
KW - Cannabinoid hyperemesis
KW - Functional dyspepsia
KW - Gastric emptying
KW - Opioids
KW - Rumination syndrome
UR - http://www.scopus.com/inward/record.url?scp=85053056312&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053056312&partnerID=8YFLogxK
U2 - 10.1016/j.giec.2018.08.004
DO - 10.1016/j.giec.2018.08.004
M3 - Review article
C2 - 30396527
AN - SCOPUS:85053056312
VL - 29
SP - 39
EP - 54
JO - Gastrointestinal Endoscopy Clinics of North America
JF - Gastrointestinal Endoscopy Clinics of North America
SN - 1052-5157
IS - 1
ER -